Literature DB >> 8795757

Lack of effect of calcium channel blockers on open-angle glaucoma.

S Liu1, S V Araujo, G L Spaeth, L J Katz, M Smith.   

Abstract

PURPOSE: The objective of this study is to evaluate the effect of calcium channel blockers (CCB) on the clinical course of glaucoma.
METHODS: Open-angle glaucoma patients receiving oral CCB for nonophthalmic diseases were sequentially selected from the private practice of the Glaucoma Service of Wills Eye Hospital. The course of visual fields and optic discs and serial intraocular pressures were analyzed in subsequent follow-ups. The findings in these 83 cases were compared with a control group of patients with the same ocular diagnosis, but who were not on CCB. A subset of 43 cases of the study group was compared with an age-matched subset of the control group.
RESULTS: There was no apparent difference in the absolute intraocular pressure, stability/change of visual fields or optic discs when we compared patients using CCB with the control group. Among patients with the diagnosis of "low-tension glaucoma," we also could not demonstrate any statistically significant difference between the two groups.
CONCLUSIONS: In this study, neither a beneficial nor a detrimental effect of CCB on the course of the patients glaucomatous disease was apparent.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8795757

Source DB:  PubMed          Journal:  J Glaucoma        ISSN: 1057-0829            Impact factor:   2.503


  6 in total

1.  A double masked placebo controlled study on the effect of nifedipine on optic nerve blood flow and visual field function in patients with open angle glaucoma.

Authors:  G Rainer; B Kiss; S Dallinger; O Findl; M Georgopoulos; C Vass; R Menapace; K Polak; H G Eichler; M Wolzt; L Schmetterer
Journal:  Br J Clin Pharmacol       Date:  2001-08       Impact factor: 4.335

2.  Fludrocortisone in the treatment of systemic hypotension in primary open-angle glaucoma patients.

Authors:  K Gugleta; S Orgül; D Stümpfig; B Dubler; J Flammer
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

3.  Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.

Authors:  Mohammed M H Al-Gayyar; Mohammed A Abdelsaid; Suraporn Matragoon; Bindu A Pillai; Azza B El-Remessy
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

4.  Potential role for angiotensin-converting enzyme inhibitors in the treatment of glaucoma.

Authors:  Kazuyuki Hirooka; Fumio Shiraga
Journal:  Clin Ophthalmol       Date:  2007-09

5.  The influence of the calcium channel blocker verapamil on experimental glaucoma.

Authors:  Irina N Mikheytseva; Ludmila T Kashintseva; George N Krizhanovsky; Olga P Kopp; Elena M Lipovetskaya
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

Review 6.  Influence of Trace Elements on Neurodegenerative Diseases of The Eye-The Glaucoma Model.

Authors:  Agnieszka Kamińska; Giovanni Luca Romano; Robert Rejdak; Sandrine Zweifel; Michal Fiedorowicz; Magdalena Rejdak; Anahita Bajka; Rosario Amato; Claudio Bucolo; Teresio Avitabile; Filippo Drago; Mario Damiano Toro
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.